Celebrating 25 years Est 1999-2024
*Across 3 years $3395.52 only $1358.21
Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 16 October 2023 – On 10 August 2023, Novo Nordisk initiated a share...
Novo Nordisk to acquire ocedurenone for uncontrolled hypertension from KBP Biosciences Bagsværd, Denmark and Singapore, 16 October 2023 –...
Novo Nordisk raises sales and operating profit outlook for 2023 Bagsværd, Denmark, 13 October 2023 – Novo Nordisk today announced that the...
Novo Nordisk will stop the once-weekly injectable semaglutide kidney outcomes trial, FLOW, based on interim analysis Novo Nordisk will stop...
Novo Nordisk A/S - share repurchase programme Bagsværd, Denmark, 09 October 2023 – On 10 August 2023, Novo Nordisk initiated a share...
Novo Nordisk A/S - share repurchase programme Bagsværd, Denmark, 02 October 2023 – On 10 August 2023, Novo Nordisk initiated a share...
Novo Nordisk A/S - share repurchase programme Bagsværd, Denmark, 25 September 2023 – On 10 August 2023, Novo Nordisk initiated a share...
Valo Health and Novo Nordisk to collaborate to discover and develop novel treatments for cardiometabolic diseases using human data and...
Novo Nordisk and UNICEF to extend joint initiative to prevent global childhood obesity New York and Bagsværd, 20 September 2023 – Novo...
Novo Nordisk A/S - share repurchase programme Bagsværd, Denmark, 18 September 2023 – On 10 August 2023, Novo Nordisk initiated a share...
Novo Nordisk A/S - share repurchase programme Bagsværd, Denmark, 13 September 2023 – On 10 August 2023, Novo Nordisk initiated a share...
Novo Nordisk conducts a two-for-one stock split Bagsværd, Denmark, 13 September 2023 – As communicated on 10 August 2023 in connection with...
Novo Nordisk A/S - share repurchase programme Bagsværd, Denmark, 4 September 2023 – On 10 August 2023, Novo Nordisk initiated a share...
Ozempic® 2.0 mg approved in the US for the treatment of type 2 diabetes Bagsværd, Denmark, 28 March 2022 – Novo Nordisk today announced that...
Novo Nordisk A/S: Share repurchase programme Bagsværd, Denmark, 28 March 2022 – On 2 February 2022, Novo Nordisk initiated a share...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.